Shaffer James P 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Shaffer James P
Chief Business Officer
Transactions
- Award
Common Stock
2020-03-05$7.31/sh+1,500$10,965→ 15,921 total - Award
Stock Option (Right to Buy)
2020-03-12+50,000→ 50,000 totalExercise: $5.60Exp: 2030-03-11→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The option vests in equal monthly installments over 48 months measured from March 12, 2020 subject to Reporting Person's continuous service status as of each such date.